Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease
Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect lepti...
Saved in:
Published in | Heart and vessels Vol. 27; no. 4; pp. 337 - 343 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Japan
Springer Japan
01.07.2012
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0910-8327 1615-2573 1615-2573 |
DOI | 10.1007/s00380-011-0156-y |
Cover
Abstract | Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all
P
< 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD. |
---|---|
AbstractList | Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all P < 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD. Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all P < 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD.[PUBLICATION ABSTRACT] Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all P < 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD.Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all P < 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD. Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all P < 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD. |
Author | Tabuchi, Tsuyoshi Nakamura, Motoyuki Takahashi, Yuji Satoh, Mamoru |
Author_xml | – sequence: 1 givenname: Yuji surname: Takahashi fullname: Takahashi, Yuji organization: Department of Internal Medicine, Division of Cardiology and Memorial Heart Center, Iwate Medical University School of Medicine – sequence: 2 givenname: Mamoru surname: Satoh fullname: Satoh, Mamoru email: m_satoh@imu.ncvc.go.jp organization: Department of Internal Medicine, Division of Cardiology and Memorial Heart Center, Iwate Medical University School of Medicine – sequence: 3 givenname: Tsuyoshi surname: Tabuchi fullname: Tabuchi, Tsuyoshi organization: Department of Internal Medicine, Division of Cardiology and Memorial Heart Center, Iwate Medical University School of Medicine – sequence: 4 givenname: Motoyuki surname: Nakamura fullname: Nakamura, Motoyuki organization: Department of Internal Medicine, Division of Cardiology and Memorial Heart Center, Iwate Medical University School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21643812$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1uFDEMxyNURD_gAbigSBzg0IF8zGZmjlXFl1QJDnAeZRLPNtVMMsTZRcvT8Cx9MrzaUqFKcLBsJb-_7cQ-ZUcxRWDsuRRvpBDNWxRCt6ISUpKtTLV7xE6kkatKrRp9xE5EJ0XVatUcs1PEG0FQJ7sn7FhJU-tWqhN2-yUnXMCVsIVznm30aQ4_wZ9zDHE9QTVMIXru0rzYHDBFnkYO40gK3Ifm9tecYrnGV7xksGWGWPiPUK65LSlvLRZbQuRbyLhBvmR7f0SpJlj2ERUlW4e0hhgcH60jKXK6WYikhHjI6FJO0eYdt7kAOR8QLMJT9ni0E8KzO3_Gvr1_9_XyY3X1-cOny4uryunOlMq3nZFeNt6KVnrndT2KzmovBgfSKTCDb32tpDJ2rH1Td0Z3YpANDAraulb6jL0-5F1y-r4BLP0c0ME02Qhpg70Uqu60aURL6MsH6E3a5Ejd9bI2SneyFoaoF3fUZpjB90sOMz2v_zMdAuQBcDQkzDDeI1L0-w3oDxvQ0wb0-w3od6RpHmhc2H84DSnbMP1XqQ5KpCpxDfmvpv8p-g38YMrG |
CODEN | HEVEEO |
CitedBy_id | crossref_primary_10_1038_s41598_020_74326_z crossref_primary_10_1016_j_biochi_2023_04_011 crossref_primary_10_3390_vaccines4030026 crossref_primary_10_1016_j_orcp_2013_04_001 crossref_primary_10_1016_j_clnu_2014_12_017 crossref_primary_10_1002_mds_26678 crossref_primary_10_14814_phy2_13566 crossref_primary_10_1007_s10552_014_0488_x crossref_primary_10_1016_j_jns_2014_11_029 crossref_primary_10_3390_biomedicines9111657 crossref_primary_10_1007_s00392_016_0996_7 crossref_primary_10_32415_jscientia_2023_9_6_6_17 crossref_primary_10_1016_j_cbi_2017_06_026 crossref_primary_10_3760_cma_j_issn_0366_6999_20140640 crossref_primary_10_3109_00365513_2015_1033742 crossref_primary_10_1038_s41598_022_16053_1 crossref_primary_10_1186_s13023_019_1211_5 crossref_primary_10_1007_s00380_012_0243_8 crossref_primary_10_1007_s00380_014_0473_z crossref_primary_10_1007_s00380_015_0686_9 crossref_primary_10_1002_art_39010 crossref_primary_10_1038_aps_2018_40 crossref_primary_10_3390_ijms22094633 crossref_primary_10_1016_j_bcp_2013_09_004 crossref_primary_10_1007_s10557_012_6412_2 crossref_primary_10_1016_j_jns_2014_11_030 crossref_primary_10_3892_etm_2014_2027 |
Cites_doi | 10.1172/JCI32239 10.1038/ijo.2008.224 10.1038/nri1350 10.1161/01.CIR.0000138112.90641.7F 10.1016/j.plipres.2004.03.001 10.1016/j.cccn.2005.04.021 10.1038/381745a0 10.1371/journal.pone.0002535 10.1126/science.281.5383.1683 10.1056/NEJMoa040583 10.1111/j.1464-5491.2006.01849.x 10.1007/s00380-010-0016-1 10.1046/j.1365-2796.1999.00571.x 10.1016/S0140-6736(05)76154-7 10.2337/diacare.28.3.754 10.1080/08037050410021405 10.1007/s00380-008-1038-9 10.1161/hc5001.101061 10.1161/01.CIR.0000033219.24717.52 10.1073/pnas.101564798 10.1016/j.atherosclerosis.2006.03.003 10.1001/jama.291.9.1071 10.1161/01.CIR.0000127960.28627.75 10.1016/j.amjcard.2005.07.013 10.1016/j.atherosclerosis.2007.01.040 10.1038/emm.2001.17 10.1093/clinchem/18.6.499 10.1161/01.CIR.0000131517.20177.5a 10.1096/fasebj.13.10.1231 |
ContentType | Journal Article |
Copyright | Springer 2011 Springer 2012 |
Copyright_xml | – notice: Springer 2011 – notice: Springer 2012 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QO 7RV 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.1007/s00380-011-0156-y |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Biotechnology Research Abstracts ProQuest Central Nursing & Allied Health database (via ProQuest) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Research Library Research Library (Corporate) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Research Library Prep MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1615-2573 |
EndPage | 343 |
ExternalDocumentID | 3140717761 21643812 10_1007_s00380_011_0156_y |
Genre | Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 203 28- 29I 29~ 2J2 2JN 2JY 2KG 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8G5 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GRRUI GUQSH GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M2O M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ZXP ~A9 ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION NAPCQ PHGZM PHGZT PJZUB PPXIY PUEGO CGR CUY CVF ECM EIF NPM 7QO 7RV 7XB 8FD 8FK FR3 K9. MBDVC P64 PKEHL PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c396t-d8961d17da081dcd34f09a3d0bce1c2e6bd8d42126af4d7496390b17eb2e84423 |
IEDL.DBID | AGYKE |
ISSN | 0910-8327 1615-2573 |
IngestDate | Sun Sep 28 02:42:12 EDT 2025 Wed Sep 17 23:56:07 EDT 2025 Thu Apr 03 06:57:04 EDT 2025 Thu Apr 24 23:10:22 EDT 2025 Wed Oct 01 01:31:21 EDT 2025 Fri Feb 21 02:27:25 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Percutaneous coronary intervention Statin Angina pectoris Atherosclerosis |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c396t-d8961d17da081dcd34f09a3d0bce1c2e6bd8d42126af4d7496390b17eb2e84423 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 ObjectType-Undefined-3 |
PMID | 21643812 |
PQID | 1462391406 |
PQPubID | 36867 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1024936708 proquest_journals_1462391406 pubmed_primary_21643812 crossref_primary_10_1007_s00380_011_0156_y crossref_citationtrail_10_1007_s00380_011_0156_y springer_journals_10_1007_s00380_011_0156_y |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20120700 2012-7-00 2012-Jul 20120701 |
PublicationDateYYYYMMDD | 2012-07-01 |
PublicationDate_xml | – month: 7 year: 2012 text: 20120700 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Tokyo |
PublicationTitle | Heart and vessels |
PublicationTitleAbbrev | Heart Vessels |
PublicationTitleAlternate | Heart Vessels |
PublicationYear | 2012 |
Publisher | Springer Japan Springer Nature B.V |
Publisher_xml | – name: Springer Japan – name: Springer Nature B.V |
References | Shamsuzzaman, Winnicki, Wolk, Svatikova, Phillips, Davison, Berger, Somers (CR27) 2004; 109 Cao (CR22) 2007; 117 Oka, Ikeda, Koga, Miyahara, Kohno (CR24) 2008; 23 von Eynatten, Schneider, Hadziselimovic, Hamman, Bierhaus, Nawroth, Dugi (CR26) 2005; 28 Sierra-Honigmann, Nath, Murakami, Garcia-Cardena, Papapetropoulos, Sessa, Madge, Schechner, Schwabb, Polverini, Flores-Riveros (CR3) 1998; 281 Bouloumie, Marumo, Lafontan, Busse (CR19) 1999; 13 Wallerstedt, Eriksson, Nikiason, Ohisson, Hedner (CR14) 2004; 13 Cannon, Braunwald, McCabe, Rader, Rouleau, Belder, Joyal, Hill, Pfeffer, Skene (CR9) 2004; 350 Davignon (CR23) 2004; 109 Strandberg, Vanhangen, Tikkanen (CR29) 1999; 353 Satani, Konya, Hamaguchi, Umehara, Katsuno, Ishikawa, Kohri, Suehiro, Kakishita, Namba (CR7) 2003; 23 Park, Kwon, Lim, Hong, Lee, Park, Jang, Cho, Kim (CR17) 2001; 33 Djoba Siawaya, Roberts, Babb, Black, Golakai, Stanley, Bapela, Hoal, Parida, van Helden, Walzl (CR11) 2008; 3 La Cava, Matarese (CR4) 2004; 4 Lee, Lip, Blann (CR6) 2004; 110 Nissen (CR10) 2005; 96 Cao, Brakenhieim, Wahlestedt, Thyberg, Cao (CR18) 2001; 98 Nissen, Tuzcu, Schoenhagen, Brown, Ganz, Vogel, Crowe, Howard, Cooper, Brodie, Grines, DeMaria (CR8) 2004; 291 Beltowski (CR2) 2006; 189 Wallace, McMahon, Packard, Kelly, Shepherd, Gaw, Sattar (CR5) 2001; 104 Singhal, Farooqi, Cole, O’Rahilly, Fewtrell, Kattenhorn, Lucas, Deanfield (CR15) 2002; 106 Peelman, Waelput, Iserentant, Lavens, Eyckerman, Zabeau, Tavernier (CR16) 2004; 43 Zhao, Wu (CR25) 2005; 360 Mavri, Poredoš, Suran, Gaborit, Juhan-Vague, Poredoš (CR20) 2011; 26 Woods, Stock (CR1) 1996; 381 Chiba, Shinozaki, Nakazawa, Kawakami, Ai, Kaneko, Kitagawa, Kondo, Chait, Shimokado (CR21) 2008; 196 Soderberg, Ahren, Jansson, Johnson, Hallmans, Asplund, Olsson (CR13) 1999; 246 Söderberg, Colquhoun, Keech, Yallop, Barnes, Pollicino, Simes, Tonkin, Nestel, Study Investigators (CR28) 2008; 33 Friedewald, Levy, Fredrickson (CR12) 1972; 18 WT Friedewald (156_CR12) 1972; 18 HY Park (156_CR17) 2001; 33 CP Cannon (156_CR9) 2004; 350 SM Wallerstedt (156_CR14) 2004; 13 T Chiba (156_CR21) 2008; 196 AS Shamsuzzaman (156_CR27) 2004; 109 Y Cao (156_CR22) 2007; 117 F Peelman (156_CR16) 2004; 43 TE Strandberg (156_CR29) 1999; 353 S Söderberg (156_CR28) 2008; 33 AJ Woods (156_CR1) 1996; 381 K Satani (156_CR7) 2003; 23 A Bouloumie (156_CR19) 1999; 13 SE Nissen (156_CR8) 2004; 291 A Singhal (156_CR15) 2002; 106 SE Nissen (156_CR10) 2005; 96 J Beltowski (156_CR2) 2006; 189 JF Djoba Siawaya (156_CR11) 2008; 3 KW Lee (156_CR6) 2004; 110 S Soderberg (156_CR13) 1999; 246 MR Sierra-Honigmann (156_CR3) 1998; 281 M Eynatten von (156_CR26) 2005; 28 SP Zhao (156_CR25) 2005; 360 R Cao (156_CR18) 2001; 98 A Mavri (156_CR20) 2011; 26 H Oka (156_CR24) 2008; 23 A La Cava (156_CR4) 2004; 4 AM Wallace (156_CR5) 2001; 104 156_CR23 10023901 - Lancet. 1999 Jan 9;353(9147):118-9 9733517 - Science. 1998 Sep 11;281(5383):1683-6 16759302 - Diabet Med. 2006 Jun;23 (6):617-22 15581339 - Blood Press. 2004;13(4):243-6 20922535 - Heart Vessels. 2011 Jan;26(1):31-8 15234549 - Prog Lipid Res. 2004 Jul;43(4):283-301 15122202 - Nat Rev Immunol. 2004 May;4(5):371-9 16014304 - Clin Chim Acta. 2005 Oct;360(1-2):133-40 17362969 - Atherosclerosis. 2008 Jan;196(1):68-75 10385613 - FASEB J. 1999 Jul;13(10):1231-8 11460888 - Exp Mol Med. 2001 Jun 30;33(2):95-102 11344271 - Proc Natl Acad Sci U S A. 2001 May 22;98(11):6390-5 15007110 - N Engl J Med. 2004 Apr 8;350(15):1495-504 10583712 - J Intern Med. 1999 Oct;246(4):409-18 15117839 - Circulation. 2004 May 11;109(18):2181-5 15198965 - Circulation. 2004 Jun 15;109(23 Suppl 1):III39-43 16580676 - Atherosclerosis. 2006 Nov;189(1):47-60 4337382 - Clin Chem. 1972 Jun;18(6):499-502 14996776 - JAMA. 2004 Mar 3;291(9):1071-80 15735224 - Diabetes Care. 2005 Mar;28(3):754-5 15302795 - Circulation. 2004 Oct 19;110(16):2355-60 18649055 - Heart Vessels. 2008 Jul;23(4):249-56 12370213 - Circulation. 2002 Oct 8;106(15):1919-24 16126025 - Am J Cardiol. 2005 Sep 5;96(5A):61F-68F 17786229 - J Clin Invest. 2007 Sep;117(9):2362-8 19050671 - Int J Obes (Lond). 2009 Jan;33(1):123-30 18596971 - PLoS One. 2008 Jul 02;3(7):e2535 11748099 - Circulation. 2001 Dec 18;104(25):3052-6 8657278 - Nature. 1996 Jun 27;381(6585):745 |
References_xml | – volume: 117 start-page: 2362 year: 2007 end-page: 2368 ident: CR22 article-title: Angiogenesis modulates adipogenesis and obesity publication-title: J Clin Invest doi: 10.1172/JCI32239 – volume: 33 start-page: 123 year: 2008 end-page: 130 ident: CR28 article-title: Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2008.224 – volume: 109 start-page: III39 issue: Suppl 1 year: 2004 end-page: 43 ident: CR23 article-title: Beneficial cardiovascular pleiotropic effects of statins publication-title: Circulation – volume: 4 start-page: 371 year: 2004 end-page: 379 ident: CR4 article-title: The weight of leptin in immunity publication-title: Nat Rev Immunol doi: 10.1038/nri1350 – volume: 110 start-page: 2355 year: 2004 end-page: 2360 ident: CR6 article-title: Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes publication-title: Circulation doi: 10.1161/01.CIR.0000138112.90641.7F – volume: 33 start-page: 95 year: 2001 end-page: 102 ident: CR17 article-title: Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro publication-title: Exp Mol Med – volume: 43 start-page: 283 year: 2004 end-page: 301 ident: CR16 article-title: Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases publication-title: Prog Lipid Res doi: 10.1016/j.plipres.2004.03.001 – volume: 360 start-page: 133 year: 2005 end-page: 140 ident: CR25 article-title: Atorvastatin reduces serum leptin concentration in hypercholesterolemic rabbits publication-title: Clin Chim Acta doi: 10.1016/j.cccn.2005.04.021 – volume: 381 start-page: 745 year: 1996 ident: CR1 article-title: Leptin activation in hypothalamus publication-title: Nature doi: 10.1038/381745a0 – volume: 18 start-page: 499 year: 1972 end-page: 502 ident: CR12 article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge publication-title: Clin Chem – volume: 3 start-page: e2535 year: 2008 ident: CR11 article-title: An evaluation of commercial fluorescent bead-based luminex cytokine assays publication-title: PLoS ONE doi: 10.1371/journal.pone.0002535 – volume: 281 start-page: 1683 year: 1998 end-page: 1686 ident: CR3 article-title: Biological action of leptin as an angiogenic factor publication-title: Science doi: 10.1126/science.281.5383.1683 – volume: 350 start-page: 1495 year: 2004 end-page: 1504 ident: CR9 article-title: Intensive versus moderate lipid lowering with statins after acute coronary syndromes publication-title: N Engl J Med doi: 10.1056/NEJMoa040583 – volume: 13 start-page: 1231 year: 1999 end-page: 1238 ident: CR19 article-title: Leptin induces oxidative stress in human endothelial cells publication-title: FASEB J – volume: 23 start-page: 617 year: 2003 end-page: 622 ident: CR7 article-title: Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with type 2 diabetes publication-title: Diabet Med doi: 10.1111/j.1464-5491.2006.01849.x – volume: 26 start-page: 31 year: 2011 end-page: 38 ident: CR20 article-title: Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting publication-title: Heart Vessels doi: 10.1007/s00380-010-0016-1 – volume: 246 start-page: 409 year: 1999 end-page: 418 ident: CR13 article-title: Leptin is associated with increased risk of myocardial infarction publication-title: J Intern Med doi: 10.1046/j.1365-2796.1999.00571.x – volume: 353 start-page: 118 year: 1999 end-page: 119 ident: CR29 article-title: Effect of statins on C-reactive protein in patients with coronary artery disease publication-title: Lancet doi: 10.1016/S0140-6736(05)76154-7 – volume: 28 start-page: 754 year: 2005 end-page: 755 ident: CR26 article-title: Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes publication-title: Diabetes Care doi: 10.2337/diacare.28.3.754 – volume: 13 start-page: 243 year: 2004 end-page: 246 ident: CR14 article-title: Serum leptin and myocardial infarction in hypertension publication-title: Blood Press doi: 10.1080/08037050410021405 – volume: 23 start-page: 249 year: 2008 end-page: 256 ident: CR24 article-title: Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases publication-title: Heart Vessel doi: 10.1007/s00380-008-1038-9 – volume: 104 start-page: 3052 year: 2001 end-page: 3056 ident: CR5 article-title: Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS) publication-title: Circulation doi: 10.1161/hc5001.101061 – volume: 106 start-page: 1919 year: 2002 end-page: 1924 ident: CR15 article-title: Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? publication-title: Circulation doi: 10.1161/01.CIR.0000033219.24717.52 – volume: 98 start-page: 6390 year: 2001 end-page: 6395 ident: CR18 article-title: Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.101564798 – volume: 189 start-page: 47 year: 2006 end-page: 60 ident: CR2 article-title: Leptin and atherosclerosis publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2006.03.003 – volume: 291 start-page: 1071 year: 2004 end-page: 1080 ident: CR8 article-title: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.291.9.1071 – volume: 109 start-page: 2181 year: 2004 end-page: 2185 ident: CR27 article-title: Independent association between plasma leptin and C-reactive protein in healthy humans publication-title: Circulation doi: 10.1161/01.CIR.0000127960.28627.75 – volume: 96 start-page: 61F year: 2005 end-page: 68F ident: CR10 article-title: Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the reversal of atherosclerosis with aggressive lipid lowering (REVERSAL) trial publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2005.07.013 – volume: 196 start-page: 68 year: 2008 end-page: 75 ident: CR21 article-title: Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2007.01.040 – volume: 110 start-page: 2355 year: 2004 ident: 156_CR6 publication-title: Circulation doi: 10.1161/01.CIR.0000138112.90641.7F – volume: 23 start-page: 249 year: 2008 ident: 156_CR24 publication-title: Heart Vessel doi: 10.1007/s00380-008-1038-9 – volume: 189 start-page: 47 year: 2006 ident: 156_CR2 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2006.03.003 – volume: 26 start-page: 31 year: 2011 ident: 156_CR20 publication-title: Heart Vessels doi: 10.1007/s00380-010-0016-1 – volume: 196 start-page: 68 year: 2008 ident: 156_CR21 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2007.01.040 – volume: 33 start-page: 95 year: 2001 ident: 156_CR17 publication-title: Exp Mol Med doi: 10.1038/emm.2001.17 – volume: 3 start-page: e2535 year: 2008 ident: 156_CR11 publication-title: PLoS ONE doi: 10.1371/journal.pone.0002535 – volume: 18 start-page: 499 year: 1972 ident: 156_CR12 publication-title: Clin Chem doi: 10.1093/clinchem/18.6.499 – volume: 98 start-page: 6390 year: 2001 ident: 156_CR18 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.101564798 – volume: 246 start-page: 409 year: 1999 ident: 156_CR13 publication-title: J Intern Med doi: 10.1046/j.1365-2796.1999.00571.x – volume: 4 start-page: 371 year: 2004 ident: 156_CR4 publication-title: Nat Rev Immunol doi: 10.1038/nri1350 – volume: 106 start-page: 1919 year: 2002 ident: 156_CR15 publication-title: Circulation doi: 10.1161/01.CIR.0000033219.24717.52 – ident: 156_CR23 doi: 10.1161/01.CIR.0000131517.20177.5a – volume: 360 start-page: 133 year: 2005 ident: 156_CR25 publication-title: Clin Chim Acta doi: 10.1016/j.cccn.2005.04.021 – volume: 281 start-page: 1683 year: 1998 ident: 156_CR3 publication-title: Science doi: 10.1126/science.281.5383.1683 – volume: 104 start-page: 3052 year: 2001 ident: 156_CR5 publication-title: Circulation doi: 10.1161/hc5001.101061 – volume: 13 start-page: 1231 year: 1999 ident: 156_CR19 publication-title: FASEB J doi: 10.1096/fasebj.13.10.1231 – volume: 33 start-page: 123 year: 2008 ident: 156_CR28 publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2008.224 – volume: 353 start-page: 118 year: 1999 ident: 156_CR29 publication-title: Lancet doi: 10.1016/S0140-6736(05)76154-7 – volume: 350 start-page: 1495 year: 2004 ident: 156_CR9 publication-title: N Engl J Med doi: 10.1056/NEJMoa040583 – volume: 28 start-page: 754 year: 2005 ident: 156_CR26 publication-title: Diabetes Care doi: 10.2337/diacare.28.3.754 – volume: 23 start-page: 617 year: 2003 ident: 156_CR7 publication-title: Diabet Med doi: 10.1111/j.1464-5491.2006.01849.x – volume: 96 start-page: 61F year: 2005 ident: 156_CR10 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2005.07.013 – volume: 117 start-page: 2362 year: 2007 ident: 156_CR22 publication-title: J Clin Invest doi: 10.1172/JCI32239 – volume: 291 start-page: 1071 year: 2004 ident: 156_CR8 publication-title: JAMA doi: 10.1001/jama.291.9.1071 – volume: 13 start-page: 243 year: 2004 ident: 156_CR14 publication-title: Blood Press doi: 10.1080/08037050410021405 – volume: 381 start-page: 745 year: 1996 ident: 156_CR1 publication-title: Nature doi: 10.1038/381745a0 – volume: 109 start-page: 2181 year: 2004 ident: 156_CR27 publication-title: Circulation doi: 10.1161/01.CIR.0000127960.28627.75 – volume: 43 start-page: 283 year: 2004 ident: 156_CR16 publication-title: Prog Lipid Res doi: 10.1016/j.plipres.2004.03.001 – reference: 12370213 - Circulation. 2002 Oct 8;106(15):1919-24 – reference: 15581339 - Blood Press. 2004;13(4):243-6 – reference: 14996776 - JAMA. 2004 Mar 3;291(9):1071-80 – reference: 9733517 - Science. 1998 Sep 11;281(5383):1683-6 – reference: 15302795 - Circulation. 2004 Oct 19;110(16):2355-60 – reference: 10023901 - Lancet. 1999 Jan 9;353(9147):118-9 – reference: 18596971 - PLoS One. 2008 Jul 02;3(7):e2535 – reference: 15007110 - N Engl J Med. 2004 Apr 8;350(15):1495-504 – reference: 15198965 - Circulation. 2004 Jun 15;109(23 Suppl 1):III39-43 – reference: 17362969 - Atherosclerosis. 2008 Jan;196(1):68-75 – reference: 11344271 - Proc Natl Acad Sci U S A. 2001 May 22;98(11):6390-5 – reference: 15735224 - Diabetes Care. 2005 Mar;28(3):754-5 – reference: 20922535 - Heart Vessels. 2011 Jan;26(1):31-8 – reference: 15234549 - Prog Lipid Res. 2004 Jul;43(4):283-301 – reference: 4337382 - Clin Chem. 1972 Jun;18(6):499-502 – reference: 10385613 - FASEB J. 1999 Jul;13(10):1231-8 – reference: 10583712 - J Intern Med. 1999 Oct;246(4):409-18 – reference: 11460888 - Exp Mol Med. 2001 Jun 30;33(2):95-102 – reference: 8657278 - Nature. 1996 Jun 27;381(6585):745 – reference: 18649055 - Heart Vessels. 2008 Jul;23(4):249-56 – reference: 16126025 - Am J Cardiol. 2005 Sep 5;96(5A):61F-68F – reference: 16759302 - Diabet Med. 2006 Jun;23 (6):617-22 – reference: 17786229 - J Clin Invest. 2007 Sep;117(9):2362-8 – reference: 16014304 - Clin Chim Acta. 2005 Oct;360(1-2):133-40 – reference: 19050671 - Int J Obes (Lond). 2009 Jan;33(1):123-30 – reference: 11748099 - Circulation. 2001 Dec 18;104(25):3052-6 – reference: 16580676 - Atherosclerosis. 2006 Nov;189(1):47-60 – reference: 15117839 - Circulation. 2004 May 11;109(18):2181-5 – reference: 15122202 - Nat Rev Immunol. 2004 May;4(5):371-9 |
SSID | ssj0015919 |
Score | 2.0841513 |
Snippet | Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 337 |
SubjectTerms | Aged Analysis of Variance Angina pectoris Angiogenesis Angiogenic Proteins - blood Angiopoietin-2 - blood Atherosclerosis Atorvastatin Calcium Biomarkers - blood Biomedical Engineering and Bioengineering Cardiac Surgery Cardiology Coronary Artery Disease - blood Coronary Artery Disease - drug therapy Down-Regulation Female Hepatocyte Growth Factor - blood Heptanoic Acids - therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Japan Leptin - blood Lipids - blood Male Medicine Medicine & Public Health Middle Aged Original Article Pravastatin - therapeutic use Prospective Studies Pyrroles - therapeutic use Single-Blind Method Statins Time Factors Treatment Outcome Vascular endothelial growth factor Vascular Endothelial Growth Factor A - blood Vascular Surgery |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9VAEB60gvgi2nqJVhlBFLSLuXWTfZIiliIoPlg4b2Gzu9EDp8nx5Bwh_jv_mTObTVSKfQiEXDYJM7vzzcyXGYDnttA6bQojcmmUyJ1qhHLSCKVZXYwhE-EJsp_k2Xn-YXG8CAG3PtAqpzXRL9S2Mxwjf0MzOs0UuQPy7fq74K5RnF0NLTSuw42EoAprdbGYHS6y1MlYa4_WGtLcYspqxr6IaFYyJYud6WMphn_t0iWweSlR6u3P6R24HYAjnoySvgvXXLsPByctOc0XA75AT-X0MfJ9uPkxZMwP4NfnTTf9TXmEZJhsd7H86ewRcpBg5URNONOimdsRYtdgIHnwrkT68O23_iXOlHTk2C2ys_5D8_9IyxaZ27Hrcb3R8yEaacWMmRbpmbR9XXakq0uDocMP0plQ1LUfRzRcTEFvBvQ00wFD7ugenJ--__LuTIS2DcJkSm6FLZVMbFJYTXDDGpvlTax0ZuPauMSkTta2tJyIlrrJbZHTEqDiOinIx3dlTvDuPuy1XeseAuoyZ8RRl4zrEqNqnbkyc4WpM0PAzUYQT0KrTKhpzq01VtVcjdnLuSI5Vyznaojg1XzLeizocdXFh5MmVGFu99UfTYzg2XyaZiWnWnTruh1dw5UYuTZeGcGDUYPmp6XkoRJOSiN4PanUX4P_71UeXf0qj-EWQblAJD6Eve1m554QXNrWT_2c-A1S0RTz priority: 102 providerName: ProQuest |
Title | Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease |
URI | https://link.springer.com/article/10.1007/s00380-011-0156-y https://www.ncbi.nlm.nih.gov/pubmed/21643812 https://www.proquest.com/docview/1462391406 https://www.proquest.com/docview/1024936708 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1615-2573 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015919 issn: 0910-8327 databaseCode: AFBBN dateStart: 19970101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1615-2573 dateEnd: 20181231 omitProxy: true ssIdentifier: ssj0015919 issn: 0910-8327 databaseCode: 7X7 dateStart: 20000101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1615-2573 dateEnd: 20181231 omitProxy: true ssIdentifier: ssj0015919 issn: 0910-8327 databaseCode: BENPR dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1615-2573 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015919 issn: 0910-8327 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1615-2573 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0015919 issn: 0910-8327 databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9RAFD7YFsQXL62XaC0jiII2ZXPZSeZxla1FsRTpwvoU5hZd3CZlkxXSX-Nv6S_znGQS1KrQh5CQTCYT5szMd-Z88w3Ac5NIGeaJ9mOuhR9bkfvCcu0LSeaiNQ4RLUH2mB_N4vfz8dyt4656tnsfkmx76mGxGwWxiERF7u-Y-80GbI3RP8HWuDV59_nDdAgejEXQSexhF4MGm_TBzL9l8vtwdAVjXomPtsPO4R047QvcsU2-HaxrdaAv_tByvOYf3YXbDoaySWc39-CGLbZhZ1KgC37WsBesJYa2M-7bcPOji7_vwOXJquzXZu4zHOZMeba4sGaf0ZTD0voKy2GYHjY3ZGXOHGWELvnlDzT7-mv1kg0Md0ZTwYx8_--SljctCkZUkXXFzldyuIVZLYmAUzD8KB5fFiWa_kIzt2EQwydOI7bqctSkzSBXDWtZqw1zoaj7MDucnr498t0uEL6OBK99kwoemCAxEtGL0SaK85GQkRkpbQMdWq5MaiiuzWUemyTGHkWMVJBYFdo0RrT4ADaLsrCPgMk0JgCjUoKJgRZKRjaNbKJVpBEHGg9GvTFk2kmk004dy2wQd26rLMMqy6jKssaDV8Mr550-yP8S7_YWlrmuoiLfK4wE-rncg2fDY2zkFLmRhS3XmIaEHUlqL_XgYWeZw9dCdHgRdoUevO6t7JfM_1WUx9dK_QRuIVB0NOVd2KxXa_sUwVit9mAjmSd7rgni-c30-OQT3p2Fk5_bxTOa |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFB5KBfVFtPWSWvUIXkA7mMt0knkQKWrZ2gs-tLBv6WRmYhe2ybrZVeKP8j_4zzwnN5Vi3_qwEDbJJOTcvnOZcxh7ZmOtwzw2XEijuHAq58pJw5UmdjEGTURTIHskRyfi03h7vMJ-9nthqKyy14mNoraloRj5G5ToMFLoDsh3s6-cpkZRdrUfodGyxb6rv6PLVr3d-4D0fR6Gux-P3494N1WAm0jJBbeJkoENYqvRGlpjI5H7SkfWz4wLTOhkZhNLeVKpc2FjgRyq_CyI0QV1iRDU6ABV_jVBKUaUn3g8OHiIDIK2tx_qNpSUuM-i-k3T0iihEjBy3rclr_-1gxfA7YXEbGPvdm-zWx1QhZ2Ws-6wFVessfWdAp308xpeQFM62sTk19j1wy5Dv85-fZ6X_e7NLUBDaMvzyQ9nt4CCElPHM8S1Fsww_hDKHLqiEjqUgB96cVa9hKEEHihWDBQc-KZp_9OkAKolWVYwm-vhL1xpShU6BeAz8fdlUqJsTAx0E4UAz3RNZKt2RUPNG_S8hqastYYuV3WXnVwJQe-x1aIs3AMGOhGEcLKEcGRgVKYjl0QuNllkEChaj_k90VLT9VCnUR7TdOj-3NA5RTqnROe09tir4ZZZ20Dksos3e05IO11SpX8432NPh9OoBSi1owtXLvEa6vxIvfgSj91vOWh4WogeMeKy0GOve5b6a_H_vcrG5a_yhN0YHR8epAd7R_sP2U2EkV0R8yZbXcyX7hFCtUX2uJEPYKdXLZC_ATXtUew |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ti9NAEB70hMMvone-RE8dQRT0wjUv3WQ_FrWcb8d9sHDfwmZ3cxZ6SWlSIf4af8v9MmeSTVBOBT8USrPdlM5s5pmdZ58BeG4SpcIi0X4stPRjKwtfWqF9qdhdtKYQ0RFkT8TxIv5wNj1zfU7rge0-lCT7Mw2s0lQ2R2tTHI0H37igxYQqToWnwm-vw42YQjVzuhbhbCwjTGXQi-3Rw4ZcNxnKmn-a4vfAdAVtXqmUdgFofhtuOeSIs97Ud-CaLfdgf1ZS1nzR4gvsuJzdJvke7H52JfN9uDzdVMNxykOkyGSqi-V3aw6RdwlW1s_pzzCox36EWBXoWB78Vlz-IE9tvtYvcSSlI-_eIqfr3xSfSFqWyOyObY3rjRo_oqlWzJkpkW5Kr_NlRd661Oh6_CBdcbKudT-jZjkFtWmxI5q26KpHd2Exf_flzbHvGjf4OpKi8U0qRWCCxCgCHEabKC4mUkVmkmsb6NCK3KSGS9FCFbFJYnoIyEkeJJTl2zQmgHcPdsqqtA8AVRoz5shTRnaBlrmKbBrZROeRJuhmPJgMVsu0UzXn5hqrbNRj7gydkaEzNnTWevBq_Mq6l_T41-CDwRUyt7prTpfCSFJqKjx4Nl6mdcnFFlXaaktjWIuR1fFSD-73LjTeLaQclZBS6MHrwad-mfxvP-Xhf41-Crunb-fZp_cnHx_BTYJ5jmR8ADvNZmsfE5Rq8ifdcvkJ5xwaZA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prospective%2C+randomized%2C+single-blind+comparison+of+effects+of+6%C2%A0months%27+treatment+with+atorvastatin+versus+pravastatin+on+leptin+and+angiogenic+factors+in+patients+with+coronary+artery+disease&rft.jtitle=Heart+and+vessels&rft.au=Takahashi%2C+Yuji&rft.au=Satoh%2C+Mamoru&rft.au=Tabuchi%2C+Tsuyoshi&rft.au=Nakamura%2C+Motoyuki&rft.date=2012-07-01&rft.issn=0910-8327&rft.eissn=1615-2573&rft.volume=27&rft.issue=4&rft.spage=337&rft.epage=343&rft_id=info:doi/10.1007%2Fs00380-011-0156-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00380_011_0156_y |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0910-8327&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0910-8327&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0910-8327&client=summon |